XML 38 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
During the year ended December 31, 2021, the Company funded $33.4 million toward development and redevelopment of properties, including the following:
•$10.1 million related to the redevelopment of a 110,883 square foot medical office building in Memphis, Tennessee.
•$7.0 million for the continued redevelopment on a 217,114 square foot medical office building in Dallas, Texas. The building continues to operate with in-place leases during construction.
•$4.1 million related to the development of a 23,000 square foot medical office building in Tacoma, Washington.
•$1.9 million related to the development of a 106,194 square foot medical office building in Nashville, Tennessee. The redevelopment includes the demolition of an existing 81,000 square foot medical office building in which the Company recognized an impairment charge of $5.0 million related to the existing building in 2021.
•$2.1 million for capital and tenant improvements of reposition properties.
•$8.2 million related to ongoing tenant improvements at previously completed projects.
The table below details the Company’s development activity as of December 31, 2021. The information included in the table below represents management’s estimates and expectations at December 31, 2021, which are subject to change. The Company’s disclosures regarding certain projections or estimates of completion dates may not reflect actual results.
December 31, 2021
Dollars in thousandsNUMBER OF PROPERTIESINITIAL OCCUPANCYCONSTRUCTION IN PROGRESS BALANCETOTAL FUNDED during the yearTOTAL AMOUNT FUNDED
Redevelopment Activity
Memphis, TN 1 Q1 2021— 10,052 31,702 
Dallas, TX1 Q1 2022— 7,036 7,460 
Tacoma, WA1 Q2 20223,974 4,147 4,147 
Nashville, TN1 Q3 2023— 1,846 1,846 
Total$3,974 $23,081 $45,155 

Tenant Improvements
The Company may provide a tenant improvement allowance in new or renewal leases for the purpose of refurbishing or renovating tenant space. As of December 31, 2021, the Company had commitments of approximately $76.1 million that are expected to be spent on tenant improvements throughout the portfolio, excluding development properties currently under construction.
Land Held for Development
Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company's land held for development included seven parcels as of December 31, 2021 and eight parcels as of December 31, 2020. The Company’s investments in land held for development totaled approximately $24.8 million as of December 31, 2021 and $27.2 million as of December 31, 2020. The current land held for development is located adjacent to certain of the Company's existing medical office buildings in Texas, Tennessee, Georgia and Colorado.